Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer

Posterior reversible encephalopathy syndrome (PRES) is an increasingly recognizable neuro-clinical syndrome. Clinical and neurological manifestations of PRES include hypertension, headache, encephalopathy, seizures, and symmetrical white matter changes on brain MRI. Most common precipitants of PRES...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamid, Mohsin, Ghani, Ali, Micaily, Ida, Sarwar, Usman, Lashari, Bilal, Malik, Faizan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998282/
https://www.ncbi.nlm.nih.gov/pubmed/29915651
http://dx.doi.org/10.1080/20009666.2018.1478563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998282/
https://www.ncbi.nlm.nih.gov/pubmed/29915651
http://dx.doi.org/10.1080/20009666.2018.1478563

Ejemplares similares